The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review

Eur Urol Focus. 2019 Nov;5(6):943-945. doi: 10.1016/j.euf.2019.03.006. Epub 2019 Mar 21.

Abstract

Overdiagnosis and overtreatment refer to the detection and treatment of conditions that would not ultimately affect an individual's health. With increasing detection of small renal masses there is growing awareness of the overdiagnosis and overtreatment of these tumors, supported by studies showing that 15-30% of nephrectomy specimens are pathologically benign, and that many small renal cell carcinomas are indolent. The harms of overdiagnosis and overtreatment are numerous, including psychosocial stressors and renal morbidity, in addition to unnecessary surgical complications. A greater understanding of the potential harms of overdiagnosis and overtreatment is crucial as clinicians focus on optimizing patient selection for renal mass biopsy, active surveillance protocols, and minimally invasive surgery. PATIENT SUMMARY: In this mini-review we discuss the issues of overdiagnosis and overtreatment in patients with kidney cancer. We enumerate the risks of overdiagnosis and overtreatment, and examine the next steps towards preventing these harms.

Keywords: Kidney cancer; Overdiagnosis; Overtreatment; Renal mass.

Publication types

  • Review

MeSH terms

  • Awareness
  • Biopsy
  • Carcinoma, Renal Cell / epidemiology
  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / surgery*
  • Decision Making, Shared
  • Humans
  • Incidence
  • Kidney Neoplasms / diagnosis*
  • Kidney Neoplasms / pathology
  • Medical Overuse / statistics & numerical data*
  • Minimally Invasive Surgical Procedures / methods
  • Nephrectomy / methods*
  • Patient Selection
  • Watchful Waiting / methods